Literature DB >> 20549240

Association between Toll-like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis.

Alisa Junpee1, Tewin Tencomnao, Vivornpun Sanprasert, Surang Nuchprayoon.   

Abstract

Lymphatic filariasis is mainly caused by the filarial nematodes Wuchereria bancrofti and Brugia malayi. Wolbachia, intracellular symbiotic bacteria in filarial parasite, is known to induce immune response predominantly through Toll-like receptor 2 (TLR2). This study was performed to investigate the association between polymorphisms of the TLR2 gene and susceptibility to asymptomatic bancroftian filariasis. A total of 142 unrelated asymptomatic bancroftian filariasis patients and 151 endemic normal controls in Tak province, Thailand were recruited into this study. The -196 to -173 deletion (del) polymorphism in the 5' untranslated region was investigated by allele-specific polymerase chain reaction. Two single nucleotide polymorphisms, +597 T>C and +1350 T>C, in exon 3 were identified by polymerase chain reaction-restriction fragment length polymorphism analysis. Furthermore, we analyzed the functional difference between the TLR2 -196 to -173 del and wild-type (wt) alleles using the luciferase reporter assay. All three polymorphisms were associated with a higher risk of asymptomatic bancroftian filariasis and were in strong linkage disequilibrium with each other. The TLR2 haplotype -196 to -173del/+597C/+1350C was strongly associated with an increased risk of asymptomatic bancroftian filariasis. The TLR2 -196 to -173 del allele had a significantly lower transcriptional activity than wt allele. The results of our study indicate that TLR2 -196 to -173 del, +597 T>C and +1350 T>C polymorphisms are associated with asymptomatic bancroftian filariasis in Thailand. Our functional study also supports this finding with respect to differential TLR2 gene expression by -196 to -173 del polymorphism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549240     DOI: 10.1007/s00436-010-1932-9

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  51 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population.

Authors:  E Noguchi; F Nishimura; H Fukai; J Kim; K Ichikawa; M Shibasaki; T Arinami
Journal:  Clin Exp Allergy       Date:  2004-02       Impact factor: 5.018

3.  Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.

Authors:  Amy G Hise; Katrin Daehnel; Illona Gillette-Ferguson; Eun Cho; Helen F McGarry; Mark J Taylor; Douglas T Golenbock; Katherine A Fitzgerald; James W Kazura; Eric Pearlman
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation.

Authors:  Subash Babu; Carla P Blauvelt; V Kumaraswami; Thomas B Nutman
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

5.  Detection and differentiation of filarial parasites by universal primers and polymerase chain reaction-restriction fragment length polymorphism analysis.

Authors:  Surang Nuchprayoon; Alisa Junpee; Yong Poovorawan; Alan L Scott
Journal:  Am J Trop Med Hyg       Date:  2005-11       Impact factor: 2.345

Review 6.  Sex differentials in susceptibility to lymphatic filariasis and implications for maternal child immunity.

Authors:  L Brabin
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

7.  Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.

Authors:  Digna Rosa Velez; Christian Wejse; Martin E Stryjewski; Eduardo Abbate; William F Hulme; Jamie L Myers; Rosa Estevan; Sara G Patillo; Rikke Olesen; Alessandra Tacconelli; Giorgio Sirugo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-09-22       Impact factor: 4.132

8.  Characterization of antibody responses to Wolbachia surface protein in humans with lymphatic filariasis.

Authors:  George A Punkosdy; David G Addiss; Patrick J Lammie
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

Authors:  Jubao Duan; Mark S Wainwright; Josep M Comeron; Naruya Saitou; Alan R Sanders; Joel Gelernter; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

10.  A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis.

Authors:  N T T Thuong; T R Hawn; G E Thwaites; T T H Chau; N T N Lan; H T Quy; N T Hieu; A Aderem; T T Hien; J J Farrar; S J Dunstan
Journal:  Genes Immun       Date:  2007-06-07       Impact factor: 2.676

View more
  19 in total

1.  Genetic predisposition of variants in TLR2 and its co-receptors to severe malaria in Odisha, India.

Authors:  Subhendu Panigrahi; Avishek Kar; Sagnika Tripathy; Manoj K Mohapatra; Gunanidhi Dhangadamajhi
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 2.  Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?

Authors:  A N Shriram; K Krishnamoorthy; B P Saha; Avijit Roy; V Kumaraswami; W A Shah; P Jambulingam; P Vijayachari
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

Review 3.  Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases.

Authors:  C Skevaki; M Pararas; K Kostelidou; A Tsakris; J G Routsias
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 4.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

Review 5.  Particularities of allergy in the Tropics.

Authors:  Luis Caraballo; Josefina Zakzuk; Bee Wah Lee; Nathalie Acevedo; Jian Yi Soh; Mario Sánchez-Borges; Elham Hossny; Elizabeth García; Nelson Rosario; Ignacio Ansotegui; Leonardo Puerta; Jorge Sánchez; Victoria Cardona
Journal:  World Allergy Organ J       Date:  2016-06-27       Impact factor: 4.084

6.  Association between TLR2 polymorphisms (- 196-174 Ins/Del, R677W, R753Q, and P631H) and schizophrenia in a Tunisian population.

Authors:  Youssef Aflouk; Oumaima Inoubli; Hana Saoud; Ferid Zaafrane; Lotfi Gaha; Besma Bel Hadj Jrad
Journal:  Immunol Res       Date:  2021-09-21       Impact factor: 2.829

7.  Genome-wide screening identifies Plasmodium chabaudi-induced modifications of DNA methylation status of Tlr1 and Tlr6 gene promoters in liver, but not spleen, of female C57BL/6 mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel Azeem S Abdel-Baki; Denis Delic; Simeon Santourlidis; Frank Wunderlich
Journal:  Parasitol Res       Date:  2013-08-16       Impact factor: 2.289

8.  Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.

Authors:  Mi Kyeong Kim; Sung Wook Park; Su Kang Kim; Hae Jeong Park; Young Gyu Eun; Kee Hwan Kwon; Jinju Kim
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

9.  Genetic polymorphisms in Toll-like receptors among pediatric patients with renal parenchymal infections of different clinical severities.

Authors:  Chi-Hui Cheng; Yun-Shien Lee; Chee-Jen Chang; Tzou-Yien Lin
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

10.  The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Khean-Lee Goh; Kwong Ming Fock; Hazel M Mitchell
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.